Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats
- PMID: 9190871
Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats
Abstract
This study investigated the effect of delta opioid receptor blockade by naltrindole on the development of physical dependence and tolerance to the antinociceptive and respiratory depressive effects of morphine in rats. Chronic morphine was delivered either by s.c. injection of increasing amounts of morphine over 5 days or by s.c. implantation of morphine pellets. Animals were cotreated with saline or naltrindole. Antinociception and respiratory depression were assessed after administration of a challenge dose of morphine, and withdrawal signs were determined after naloxone challenge. Naltrindole significantly attenuated the development of antinociceptive tolerance after all three chronic treatment regimens. In addition, rats pretreated with naltrindole displayed significantly fewer withdrawal symptoms and less weight loss after a naloxone challenge. In contrast, naltrindole did not prevent the development of tolerance to morphine-induced respiratory depression. These results imply that tolerance to antinociception and physical dependence involves adaptations at interacting mu and delta receptor populations, whereas tolerance to respiratory depression reflects actions of independent mu and delta receptor populations. These findings suggest that delta antagonists may have potential clinical application for decreasing the rapid development of tolerance to opiate-induced analgesia, while allowing for the development of protective tolerance to respiratory depression.
Similar articles
-
Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.J Pharmacol Exp Ther. 1991 Jul 1;258(1):299-303. J Pharmacol Exp Ther. 1991. PMID: 1649297
-
Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.Eur J Neurosci. 2015 Apr;41(7):901--7. doi: 10.1111/ejn.12829. Epub 2015 Jan 9. Eur J Neurosci. 2015. PMID: 25639561 Free PMC article.
-
Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.Eur J Pharmacol. 1996 Apr 4;300(1-2):17-24. doi: 10.1016/0014-2999(95)00860-8. Eur J Pharmacol. 1996. PMID: 8741160
-
Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.Eur J Pharmacol. 2007 Apr 10;560(2-3):132-41. doi: 10.1016/j.ejphar.2006.12.013. Epub 2007 Jan 17. Eur J Pharmacol. 2007. PMID: 17307158
-
Are astroglial cells involved in morphine tolerance?Neurochem Res. 1988 Feb;13(2):87-103. doi: 10.1007/BF00973320. Neurochem Res. 1988. PMID: 3283589 Review.
Cited by
-
Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.Br J Pharmacol. 2002 Jan;135(1):217-25. doi: 10.1038/sj.bjp.0704430. Br J Pharmacol. 2002. PMID: 11786497 Free PMC article.
-
Structural Simplification of a Tetrahydroquinoline-Core Peptidomimetic μ-Opioid Receptor (MOR) Agonist/δ-Opioid Receptor (DOR) Antagonist Produces Improved Metabolic Stability.J Med Chem. 2019 Apr 25;62(8):4142-4157. doi: 10.1021/acs.jmedchem.9b00219. Epub 2019 Apr 12. J Med Chem. 2019. PMID: 30924650 Free PMC article.
-
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.J Med Chem. 2015 Nov 25;58(22):8952-69. doi: 10.1021/acs.jmedchem.5b01270. Epub 2015 Nov 13. J Med Chem. 2015. PMID: 26524472 Free PMC article.
-
Placement of Hydroxy Moiety on Pendant of Peptidomimetic Scaffold Modulates Mu and Kappa Opioid Receptor Efficacy.ACS Chem Neurosci. 2017 Nov 15;8(11):2549-2557. doi: 10.1021/acschemneuro.7b00284. Epub 2017 Aug 25. ACS Chem Neurosci. 2017. PMID: 28796483 Free PMC article.
-
The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.Psychopharmacology (Berl). 2016 Jul;233(13):2479-87. doi: 10.1007/s00213-016-4296-8. Epub 2016 Apr 27. Psychopharmacology (Berl). 2016. PMID: 27117141 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials